Health ❯ Healthcare ❯ Health Economics

Cost-Effectiveness

NHS Funding Pharmacogenomic Testing Preventive Surgery Preventive Interventions Screening Programs AI Cost Management Quality-Adjusted Life Years (QALYs) Pharmacogenomic Interventions Healthcare Savings

NICE Endorses Dupilumab as First Targeted Biologic for Uncontrolled Eosinophilic COPD

NHS funding will begin within 90 days of final guidance under strict eligibility plus a 12‑month stop review.

Annals Study Finds GLP-1s Cost-Effective for Knee Osteoarthritis, With Tirzepatide Beating Semaglutide

Researchers Propose Widening Preventive Mastectomy Access to Avert 6,500 UK Breast Cancer Cases a Year

NHS PROGRESS Study Embeds Pharmacogenomics in Primary Care, Alters Treatment for 25% of Patients